Hanna Vasarainen

Short‐term outcomes of the prospective multicentre ‘Prostate Cancer Research International: Active Surveillance’ study

Roderick C.N. van den Bergh, Hanna Vasarainen, Henk G. van der Poel et al. · British Journal of Urology · 2009 · 164 citations

Outcomes of initially expectantly managed patients with low or intermediate risk screen‐detected localized prostate cancer

Meelan Bul, Roderick C.N. van den Bergh, Xiaoye Zhu et al. · British Journal of Urology · 2012 · 146 citations

Prostate cancer active surveillance and health‐related quality of life: results of the Finnish arm of the prospective trial

Hanna Vasarainen, Utku Lokman, Mirja Ruutu et al. · British Journal of Urology · 2011 · 63 citations

PTEN Loss but Not ERG Expression in Diagnostic Biopsies Is Associated with Increased Risk of Progression and Adverse Surgical Findings in Men with Prostate Cancer on Active Surveillance

Utku Lokman, Andrew Erickson, Hanna Vasarainen et al. · European Urology Focus · 2017 · 50 citations · Full text

Loss of PTEN expression in ERG-negative prostate cancer predicts secondary therapies and leads to shorter disease-specific survival time after radical prostatectomy

Kanerva Lahdensuo, Andrew Erickson, Irena Saarinen et al. · Modern Pathology · 2016 · 46 citations · Full text

Urology, Perineural Invasion, Genitourinary Cancer +9